MAximising Therapeutic Utility in Rheumatoid Arthritis
Highlights and News
- Deep molecular profiling of synovial biopsies in the STRAP trial identifies signatures predictive of treatment response to biologic therapies in rheumatoid arthritis - Nature
- Deep molecular profiling of synovial biopsies in the STRAP trial identifies signatures predictive of treatment response to biologic therapies in rheumatoid arthritis Nature
- Is There a Missing Link in Rheumatoid Arthritis Management? - EMJ
- Is There a Missing Link in Rheumatoid Arthritis Management? EMJ
- Associations between rheumatoid arthritis clinical factors with synovial cell types and states - medRxiv
- Associations between rheumatoid arthritis clinical factors with synovial cell types and states medRxiv
- Clinical Applications of Synovial Biopsy - Frontiers
- Clinical Applications of Synovial Biopsy Frontiers
- Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial - The Lancet
- Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial The Lancet
- Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial - Nature
- Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial Nature
- Utility of Baseline Transcriptomic Analysis of Rheumatoid Arthritis Synovium as an Indicator for Long-Term Clinical Outcomes - Frontiers
- Utility of Baseline Transcriptomic Analysis of Rheumatoid Arthritis Synovium as an Indicator for Long-Term Clinical Outcomes Frontiers
- Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue - Nature
- Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue Nature
Related
- What is MATURA?
- EPIC-RA – Patient Survey
- Get Involved MPAG
- Highlights and News
The MATURA consortium includes academic groups and industry partners working together to identify and test biomarkers
predictive of response to biological therapy in patients with rheumatoid arthritis
predictive of response to biological therapy in patients with rheumatoid arthritis